<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00065702</url>
  </required_header>
  <id_info>
    <org_study_id>R21AT000315-01</org_study_id>
    <secondary_id>BellI</secondary_id>
    <nct_id>NCT00065702</nct_id>
  </id_info>
  <brief_title>Biomarkers of Homeopathy in Fibromyalgia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Center for Complementary and Integrative Health (NCCIH)</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of individualized classical homeopathy&#xD;
      in treatment of persons with fibromyalgia and to determine the usefulness of&#xD;
      electroencephalographic and electrocardiographic measures to serve as markers of differences&#xD;
      between active and placebo treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2000</start_date>
  <completion_date>September 2002</completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>60</enrollment>
  <condition>Fibromyalgia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Active liquid remedy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  ACR diagnosis of fibromyalgia;&#xD;
&#xD;
          -  Willing to take daily active or placebo liquid remedy under double blind conditions&#xD;
             for 6 months, involving daily succussion and dilution of source liquid from a stock&#xD;
             bottle;&#xD;
&#xD;
          -  Willingness/ability to comply with dietary and lifestyle restrictions, i.e., no coffee&#xD;
             in any form, no comphor or menthol-containing products; no electric blankets, no&#xD;
             strong aromatics, no routine vaccinations, no concomitant use of acupuncture,&#xD;
             chiropractic, polarity therapy, psychic healing, or magnet therapy;&#xD;
&#xD;
          -  No dental drilling, MRI scans unless emergent;&#xD;
&#xD;
          -  Withhold food or drink 30 mins before/after therapy;&#xD;
&#xD;
          -  Stable conventional care for 2 months prior to entry;&#xD;
&#xD;
          -  Willing to undergo 3 diagnostic physical exams, and to permit videotaping of interview&#xD;
             sessions;&#xD;
&#xD;
          -  Willing to fill out questionnaires&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Steroid-dependent medical conditions;&#xD;
&#xD;
          -  Chronic benzodiazepine or anticonvulsant use;&#xD;
&#xD;
          -  Use of tricyclic antidepressants, antihypertensives, and other drugs that alter&#xD;
             orthostasis;&#xD;
&#xD;
          -  Pregnancy;&#xD;
&#xD;
          -  History of seizure disorder or syncope;&#xD;
&#xD;
          -  Life-threatening medical conditions;&#xD;
&#xD;
          -  Current active asthma;&#xD;
&#xD;
          -  History of anaphylactic shock;&#xD;
&#xD;
          -  Insulin-dependent diabetes;&#xD;
&#xD;
          -  Active suicidal ideation or psychosis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Iris R. Bell, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arizona College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>U of Arizona College of Medicine, Program in Integrative Medicine</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2006</verification_date>
  <study_first_submitted>July 31, 2003</study_first_submitted>
  <study_first_submitted_qc>July 31, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2003</study_first_posted>
  <last_update_submitted>August 17, 2006</last_update_submitted>
  <last_update_submitted_qc>August 17, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2006</last_update_posted>
  <keyword>fibromyalgia</keyword>
  <keyword>homeopathy</keyword>
  <keyword>EEG</keyword>
  <keyword>EKG</keyword>
  <keyword>chronic pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

